GH Research PLC (GHRS)
NASDAQ: GHRS · Real-Time Price · USD
28.26
-0.46 (-1.60%)
At close: Sep 18, 2026, 4:00 PM EDT
28.26
0.00 (0.00%)
After-hours: Sep 18, 2026, 5:29 PM EDT
GH Research Market Cap
GH Research has a market cap or net worth of $1.94 billion as of September 18, 2026. Its market cap has increased by 150.18% in one year.
Market Cap
1.94B
Enterprise Value
1.58B
1-Year Change
150.18%
Ranking
Category
Stock Price
$28.26
ChartMarket Cap Chart
Since the IPO on June 25, 2021, GH Research's market cap has increased from $808.33M to $1.94B, an increase of 139.98%. That is a compound annual growth rate of 18.20%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 1.94B | 146.24% |
| Dec 31, 2025 | 787.77M | 116.30% |
| Dec 31, 2024 | 364.20M | 20.71% |
| Dec 29, 2023 | 301.72M | -40.33% |
| Dec 30, 2022 | 505.64M | -58.34% |
| Dec 31, 2021 | 1.21B | 50.14% |
| Jun 25, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Agios Pharmaceuticals | 1.96B |
| ADMA Biologics | 1.93B |
| Mesoblast | 1.89B |
| Fortrea Holdings | 1.88B |
| Hemab Therapeutics Holdings | 1.87B |
| Biohaven | 1.86B |
| Zymeworks | 1.85B |
| Stoke Therapeutics | 1.82B |